McCormik PA, Burroughs AKCirculatory disorders and vascular disease affecting the liver. In: Prieto J, Rodes J, Shafritz DA (eds). Hepatobiliary Diseases . Springer: Berlin, Heidelberg, New York , London , Paris, Tokyo, Hong Kong, Barcelona , Budapest , 1992, pp. 983-998.
2.
Shimizu S. et al. Budd-Chiari syndrome combined with antiphospholid syndrome: case report and literature review. Vasc Surg1993; 27: 501-509.
3.
Ouwendijk RJTh et al. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment . Gut1994; 35: 1004-1006.
4.
Hughes Grv.The antiphospholipid syndrome: ten years on. Lancet1993; 342: 341-344.
5.
Hughes Grv.Connective tissue disease and the skin. Clin Exp Dermatol1984; 9: 535-544.
6.
Farrant JM, Judge M., Thompson Rph.Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clin Exp Dermatol1989; 14: 306-308.
7.
Triplett DA et al. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA1988; 259: 550-594.
8.
Zarrabi MH et al. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med1979; 91: 194-199.
9.
Dilawari JB et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine1994; 73: 21-36.
10.
Pelletier S. et al. The antiphospholipid syndrome as the second cause of the non-malignant Budd-Chiari syndrome. Arthritis Rheum1992; 35 (Suppl.): S238 (abstract).